Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy
1 other identifier
observational
500
1 country
1
Brief Summary
This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 6, 2025
CompletedFirst Posted
Study publicly available on registry
August 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2031
August 15, 2025
July 1, 2025
8 years
August 6, 2025
August 13, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
eye morphological parameters
Margin reflex distances(mm)
through study completion, average of 5 years
Blinking feature of patients with thyroid-associated ophthalmopathy
Blinking frequency
through study completion, average of 5 years
Ocular movement measurement
Ocular movement ability in nine gaze positions
through study completion, average of 5 years
Automatic orbital structures segmentation and measurement using deep learning methods
Automatic segmentation and measurement of orbital structures,such as eyeball, extraocular muscle, orbital fat, bony orbital region, optic nerves, etc
through study completion, average of 5 years
Automatic diagnosis, grading, staging and prediction of patients with thyroid-associated ophthalmopathy
Patients with thyroid-associated ophthalmopathy(TAO) are classified as TAO or non-TAO. Grading is classified as mild, moderate, severe and sight-threatening. Staging is classified as active and stable.
through study completion, average of 5 years
three-dimensional eye parameters
eyelid volume
through study completion, average of 5 years
Study Arms (2)
Participants without Thyroid-associated ophthalmopathy
Participants without thyroid-associated ophthalmopathy based on Bartley criteria.
Patients with Thyroid-associated ophthalmopathy
Patients diagnosed as thyroid-associated ophthalmopathy based on Bartley criteria.
Interventions
2D and 3D Facial photography, blinking videos, orbital CT and MRI images, fundus images and images of nine gaze positions are taken. Clinical information is recorded. Quality of life is assessed. Ocular examinations, such as visual acuity, levator function, exophthalmos measurement, strabismus test, visual field examination, axial length measurement, OCT, OCTA are made.
Eligibility Criteria
500 patients with thyroid-associated ophthalomopahty 500 patients without thyroid-associated ophthalomopahty
You may qualify if:
- normal participants without eyelid disorders (control group)
- patients with thyroid-associated ophthalmopathy (TAO group)
- cooperative participants
You may not qualify if:
- participants with pupil or cornea disorders
- participants with history of eye injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Juan Ye
Hangzhou, Zhejiang, 310000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2025
First Posted
August 15, 2025
Study Start
October 1, 2022
Primary Completion (Estimated)
October 1, 2030
Study Completion (Estimated)
October 1, 2031
Last Updated
August 15, 2025
Record last verified: 2025-07